3hon MSN
Targeting tumor supporting cells: Lipid nanoparticles advance CAR T success in pancreatic cancer
Often diagnosed when surgery is no longer an option, pancreatic cancer is one of the most difficult cancers to treat and has ...
Often diagnosed when surgery is no longer an option, pancreatic cancer is one of the most difficult cancers to treat and has ...
Researchers at VCU Massey Comprehensive Cancer Center are leading an international study that advances the understanding of ...
Researchers at National Jewish Health and collaborating institutions have uncovered a critical mechanism driving persistent ...
Jen Davis (left) and Bella Reichardt (right) conducting research in a lab for genetic engineering of heart fibroblasts.at the UW Medicine Institute for Stem Cell and Regeneration Medicine. Fibroblasts ...
FibroBiologics will present on fibroblast-based therapies for chronic diseases at a conference in Freiburg, Germany, on March 27, 2025. FibroBiologics, Inc., a biotechnology company focused on ...
Chimeric antigen receptor T-cell therapy—CAR T for short—has been a major advance in treating blood cancers like leukemia and ...
Scientists from National Taiwan University (NTU) and Linkou Chang Gung Memorial Hospital (CGMH) have developed a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results